Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.16 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.41.
Market Cap
9.16T
Revenue
4.67T
Profits
189.14B
PE Ratio
48.41
Profit Margin
4.05%
Dividend Yield
0.39%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | -0.19% | 1,886,773 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 643.92B | 0.33% | 5,284,692 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 464.82B | 0.49% | 5,120,217 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 354.75B | -0.15% | 8,296,251 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 337.43B | -1.99% | 4,393,583 | 450.53B |
| 6 | NVS | Novartis AG | 264.17B | -0.27% | 2,366,983 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 253.42B | -1.18% | 2,939,378 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 237.15B | 4.61% | 3,022,817 | 46.34B |
| 9 | AMGN | Amgen Inc. | 203.09B | -1.53% | 2,608,960 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 188.46B | -2.12% | 8,862,136 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 181.41B | 0.49% | 4,536,023 | 30.46B |
| 12 | ABT | Abbott Laboratories | 176.55B | -1.03% | 7,419,448 | 46.59B |
| 13 | PFE | Pfizer Inc. | 157.03B | -0.61% | 40,435,989 | 63.70B |
| 14 | DHR | Danaher Corporation | 147.18B | 3.01% | 3,505,076 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 133.24B | -0.21% | 1,983,549 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 130.44B | -0.94% | 824,878 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 130.18B | -0.58% | 9,996,154 | 49.19B |
| 18 | CVS | CVS Health Corporation | 120.85B | -1.11% | 5,002,390 | 412.65B |
| 19 | MDT | Medtronic plc | 119.92B | -0.05% | 7,147,301 | 37.54B |
| 20 | SYK | Stryker Corporation | 107.98B | -0.13% | 3,463,076 | 25.84B |
| 21 | MCK | McKesson Corporation | 104.88B | -1.25% | 1,151,055 | 410.98B |
| 22 | SNY | Sanofi | 102.64B | -2.15% | 2,681,965 | 55.89B |
| 23 | GSK | GSK plc | 100.18B | -0.08% | 2,739,769 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 91.76B | -0.39% | 1,256,163 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 90.55B | -1.58% | 1,475,519 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.30B | -2.47% | 540,838 | 15.53B |
| 27 | CI | The Cigna Group | 76.34B | -0.40% | 1,257,263 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 63.58B | -2.62% | 16,015,359 | 21.00B |
| 29 | ARGX | argenx SE | 62.00B | -1.09% | 235,294 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.69B | -0.90% | 913,496 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.19B | 0.54% | 2,678,362 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 57.40B | -1.99% | 8,414,686 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.11B | -0.95% | 1,796,365 | 254.25B |
| 34 | BDX | Becton, Dickinson and Company | 50.64B | 1.65% | 2,087,508 | 22.48B |
| 35 | NTRA | Natera, Inc. | 50.56B | 2.63% | 1,773,488 | 2.71B |
| 36 | EW | Edwards Lifesciences Corporation | 49.42B | 0.26% | 3,777,644 | 6.51B |
| 37 | HUM | Humana Inc. | 47.63B | -2.56% | 852,090 | 145.68B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 45.74B | 1.37% | 7,128,202 | 17.32B |
| 39 | IQV | IQVIA Holdings Inc. | 44.39B | 1.51% | 1,439,159 | 16.98B |
| 40 | RVMD | Revolution Medicines, Inc. | 43.91B | -0.12% | 1,267,651 | - |
| 41 | VEEV | Veeva Systems Inc. | 43.17B | 0.36% | 1,350,529 | 3.46B |
| 42 | A | Agilent Technologies, Inc. | 42.37B | 2.36% | 1,682,268 | 7.37B |
| 43 | MDLN | Medline Inc. | 42.22B | -1.47% | 7,280,176 | 29.94B |
| 44 | WAT | Waters Corporation | 40.98B | 1.73% | 825,203 | 4.64B |
| 45 | HLN | Haleon plc | 40.45B | -1.60% | 15,422,837 | 14.80B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.24B | 0.23% | 603,673 | 4.55B |
| 47 | ONC | BeOne Medicines AG | 39.40B | -2.07% | 257,300 | 6.13B |
| 48 | RPRX | Royalty Pharma plc | 33.62B | -0.98% | 2,732,060 | 2.54B |
| 49 | ILMN | Illumina, Inc. | 33.57B | 6.76% | 3,148,819 | 4.49B |
| 50 | CNC | Centene Corporation | 33.42B | -2.52% | 3,579,376 | 180.30B |
| 51 | RMD | ResMed Inc. | 32.82B | 2.89% | 1,641,047 | 5.65B |
| 52 | DXCM | DexCom, Inc. | 32.62B | 2.09% | 5,961,134 | 4.97B |
| 53 | ALC | Alcon Inc. | 32.57B | 0.03% | 1,507,957 | 10.86B |
| 54 | BIIB | Biogen Inc. | 31.94B | -0.55% | 755,891 | 10.03B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.88B | -4.69% | 2,175,145 | 4.80B |
| 56 | ZTS | Zoetis Inc. | 30.34B | -0.33% | 4,080,129 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 28.94B | -0.28% | 4,255,163 | 21.27B |
| 58 | ROIV | Roivant Sciences Ltd. | 28.53B | -3.71% | 8,104,983 | 7.53M |
| 59 | DGX | Quest Diagnostics Incorporated | 27.27B | 3.86% | 1,373,605 | 11.56B |
| 60 | MTD | Mettler-Toledo International Inc. | 26.66B | 3.47% | 211,740 | 4.13B |
| 61 | LH | Labcorp Holdings Inc. | 26.27B | 2.75% | 878,283 | 14.35B |
| 62 | INSM | Insmed Incorporated | 26.19B | -4.29% | 3,364,509 | 1.14B |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.69B | 2.76% | 981,888 | 3.33B |
| 64 | INCY | Incyte Corporation | 24.68B | -0.37% | 1,553,682 | 5.82B |
| 65 | PHG | Koninklijke Philips N.V. | 24.35B | -0.72% | 814,948 | 20.18B |
| 66 | BNTX | BioNTech SE | 24.29B | -2.20% | 590,845 | 3.03B |
| 67 | GH | Guardant Health, Inc. | 23.57B | 4.65% | 2,852,668 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.46B | -0.47% | 1,604,660 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.00B | -1.38% | 518,745 | 21.81B |
| 70 | STE | STERIS plc | 20.50B | -1.58% | 778,964 | 6.04B |
| 71 | GMAB | Genmab A/S | 19.84B | 4.59% | 3,085,201 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.12B | -0.06% | 6,844,833 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.77B | 1.94% | 3,616,088 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.32B | 4.21% | 303,853 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 15.75B | -9.49% | 2,956,308 | 1.20B |
| 76 | RVTY | Revvity, Inc. | 15.64B | 9.11% | 3,693,791 | 2.91B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.63B | -2.05% | 702,580 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.33B | 0.27% | 1,103,095 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 15.25B | -4.58% | 1,332,180 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.10B | 1.23% | 1,980,423 | 2.44B |
| 81 | SMMT | Summit Therapeutics Inc. | 13.88B | -5.54% | 5,796,293 | - |
| 82 | BBIO | BridgeBio Pharma, Inc. | 13.37B | -5.51% | 3,962,304 | 713.07M |
| 83 | ICLR | ICON Public Limited Company | 13.31B | 2.08% | 862,405 | 8.29B |
| 84 | CRL | Charles River Laboratories International, Inc. | 13.03B | -0.08% | 983,746 | 4.00B |
| 85 | PEN | Penumbra, Inc. | 12.54B | -0.45% | 500,839 | 1.50B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.48B | -2.95% | 1,853,709 | 3.41B |
| 87 | TEM | Tempus AI, Inc. | 12.42B | 10.67% | 8,248,848 | 1.43B |
| 88 | BAX | Baxter International Inc. | 12.26B | -0.63% | 6,145,777 | 11.47B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.26B | -2.42% | 1,409,458 | 14.37B |
| 90 | DVA | DaVita Inc. | 12.17B | 0.83% | 685,927 | 14.01B |
| 91 | FMS | Fresenius Medical Care AG | 12.17B | 0.44% | 446,184 | 22.19B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.09B | -3.11% | 259,408 | 1.28B |
| 93 | HALO | Halozyme Therapeutics, Inc. | 12.06B | -1.57% | 1,055,575 | 1.66B |
| 94 | EHC | Encompass Health Corporation | 12.04B | -0.43% | 791,773 | 6.21B |
| 95 | CORT | Corcept Therapeutics Incorporated | 11.98B | -0.88% | 1,458,655 | 830.81M |
| 96 | SNN | Smith & Nephew plc | 11.77B | -1.37% | 1,667,193 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.49B | -0.65% | 8,415,632 | 5.02B |
| 98 | TECH | Bio-Techne Corporation | 11.34B | 0.10% | 2,920,451 | 1.22B |
| 99 | MOH | Molina Healthcare, Inc. | 10.78B | -3.31% | 445,044 | 42.47B |
| 100 | AXSM | Axsome Therapeutics, Inc. | 10.69B | -5.78% | 591,321 | 776.57M |
| 101 | AVTR | Avantor, Inc. | 10.44B | 1.85% | 8,185,326 | 6.56B |
| 102 | ALGN | Align Technology, Inc. | 10.44B | -3.92% | 1,025,118 | 4.14B |
| 103 | UHS | Universal Health Services, Inc. | 10.42B | 2.08% | 804,521 | 18.11B |
| 104 | COO | The Cooper Companies, Inc. | 10.13B | -1.75% | 4,416,767 | 4.24B |
| 105 | GKOS | Glaukos Corporation | 10.12B | 0.34% | 658,902 | 612.84M |
| 106 | BIO | Bio-Rad Laboratories, Inc. | 10.11B | 2.56% | 519,128 | 2.59B |
| 107 | GMED | Globus Medical, Inc. | 10.03B | -1.43% | 1,940,985 | 3.14B |
| 108 | OSCR | Oscar Health, Inc. | 10.00B | -4.05% | 4,266,903 | 15.32B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 9.98B | -3.02% | 4,228,076 | 3.50B |
| 110 | ENSG | The Ensign Group, Inc. | 9.98B | -1.25% | 405,535 | 5.49B |
| 111 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.98B | -12.40% | 4,371,003 | 669.50M |
| 112 | KRYS | Krystal Biotech, Inc. | 9.97B | -0.99% | 225,769 | 440.48M |
| 113 | RGEN | Repligen Corporation | 9.86B | 4.01% | 891,256 | 785.10M |
| 114 | HSIC | Henry Schein, Inc. | 9.75B | -1.59% | 1,551,487 | 13.60B |
| 115 | TXG | 10x Genomics, Inc. | 9.69B | 6.10% | 2,904,682 | 616.91M |
| 116 | PODD | Insulet Corporation | 9.66B | 1.04% | 1,495,873 | 3.05B |
| 117 | CYTK | Cytokinetics, Incorporated | 9.64B | -4.33% | 2,576,598 | 67.67M |
| 118 | ABVX | ABIVAX Société Anonyme | 9.44B | -6.09% | 2,007,956 | 5.67M |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.41B | -1.29% | 900,882 | 105.00M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.28B | -2.96% | 604,907 | 281.99M |
| 121 | PCVX | Vaxcyte, Inc. | 8.81B | -0.55% | 1,887,866 | - |
| 122 | QGEN | Qiagen N.V. | 8.78B | 1.43% | 1,781,303 | 2.10B |
| 123 | PRAX | Praxis Precision Medicines, Inc. | 8.74B | -5.34% | 205,651 | 7.46M |
| 124 | TWST | Twist Bioscience Corporation | 8.66B | 2.49% | 1,288,081 | 431.80M |
| 125 | IBRX | ImmunityBio, Inc. | 8.63B | -2.75% | 8,949,305 | 165.79M |
| 126 | BRKR | Bruker Corporation | 8.49B | 5.87% | 2,956,996 | 3.50B |
| 127 | CAI | Caris Life Sciences, Inc. | 8.05B | 9.40% | 8,842,496 | 989.61M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 8.02B | 0.17% | 858,480 | - |
| 129 | HQY | HealthEquity, Inc. | 7.98B | 0.49% | 1,119,428 | 1.36B |
| 130 | ATR | AptarGroup, Inc. | 7.93B | -0.18% | 474,727 | 3.93B |
| 131 | IONS | Ionis Pharmaceuticals, Inc. | 7.85B | -8.15% | 6,812,338 | 874.09M |
| 132 | ALKS | Alkermes plc | 7.72B | 0.44% | 2,151,151 | 1.67B |
| 133 | IMVT | Immunovant, Inc. | 7.57B | -2.68% | 1,574,047 | - |
| 134 | TGTX | TG Therapeutics, Inc. | 7.52B | -1.78% | 1,298,405 | 799.54M |
| 135 | HNGE | Hinge Health, Inc. | 7.46B | -2.53% | 1,163,485 | 720.06M |
| 136 | BLTE | Belite Bio, Inc | 6.82B | -2.06% | 151,848 | - |
| 137 | PACS | PACS Group, Inc. | 6.66B | -5.52% | 1,012,150 | 5.55B |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.66B | -5.53% | 914,269 | 239.92M |
| 139 | GRFS | Grifols, S.A. | 6.64B | -1.60% | 590,607 | 8.48B |
| 140 | CHE | Chemed Corporation | 6.59B | -1.52% | 176,422 | 2.60B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.57B | 0.41% | 1,142,726 | 1.56B |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.50B | -3.33% | 8,159,959 | 2.58B |
| 143 | CGON | CG Oncology, Inc. | 6.43B | -1.68% | 1,037,317 | 6.23M |
| 144 | MMED | MiniMed Group, Inc. | 6.19B | 0.18% | 2,127,115 | 3.22B |
| 145 | BLCO | Bausch + Lomb Corporation | 6.15B | -1.99% | 361,544 | 5.32B |
| 146 | ORKA | Oruka Therapeutics, Inc. | 6.10B | -3.89% | 784,616 | - |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.10B | -2.95% | 927,760 | 618.07M |
| 148 | SRRK | Scholar Rock Holding Corporation | 6.09B | -3.57% | 5,250,473 | - |
| 149 | RDNT | RadNet, Inc. | 6.07B | 2.16% | 1,589,478 | 2.27B |
| 150 | TVTX | Travere Therapeutics, Inc. | 5.89B | -4.99% | 2,097,797 | 591.33M |
| 151 | STVN | Stevanato Group S.p.A. | 5.88B | 1.03% | 295,063 | 1.40B |
| 152 | LQDA | Liquidia Corporation | 5.88B | 0.63% | 1,372,016 | 450.91M |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.86B | -1.87% | 488,918 | 840.85M |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 5.86B | -2.71% | 478,961 | 1.90M |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 5.80B | -3.31% | 1,793,426 | 3.12B |
| 156 | ERAS | Erasca, Inc. | 5.68B | 0.56% | 4,691,502 | - |
| 157 | COGT | Cogent Biosciences, Inc. | 5.68B | -2.01% | 1,712,350 | - |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 5.52B | -1.31% | 180,222 | 290.54M |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.48B | -1.25% | 1,034,202 | 1.01B |
| 160 | TFX | Teleflex Incorporated | 5.47B | -0.98% | 803,746 | 2.25B |
| 161 | XENE | Xenon Pharmaceuticals Inc. | 5.45B | -3.28% | 467,995 | 7.50M |
| 162 | SHC | Sotera Health Company | 5.42B | 2.48% | 1,815,335 | 1.22B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.15B | -0.97% | 533,146 | 1.58B |
| 164 | WAY | Waystar Holding Corp. | 5.11B | 7.11% | 5,679,596 | 1.21B |
| 165 | CRSP | CRISPR Therapeutics AG | 5.01B | -2.13% | 1,248,344 | 13.39M |
| 166 | LFST | LifeStance Health Group, Inc. | 4.99B | -2.39% | 6,433,168 | 1.58B |
| 167 | DFTX | Definium Therapeutics, Inc. | 4.95B | -8.52% | 4,526,872 | - |
| 168 | BLLN | BillionToOne, Inc. | 4.92B | 3.42% | 375,520 | 397.41M |
| 169 | HAE | Haemonetics Corporation | 4.83B | -0.10% | 440,031 | 1.35B |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.74B | -2.22% | 2,969,594 | - |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | 4.61B | -2.76% | 1,109,417 | 1.14B |
| 172 | DOCS | Doximity, Inc. | 4.60B | -2.20% | 2,559,160 | 655.57M |
| 173 | CON | Concentra Group Holdings Parent, Inc. | 4.54B | -0.53% | 829,950 | 2.29B |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.41B | -1.22% | 446,204 | 148.00K |
| 175 | LIVN | LivaNova PLC | 4.38B | -1.40% | 587,208 | 1.47B |
| 176 | MANE | Veradermics, Incorporated | 4.34B | 2.15% | 938,958 | - |
| 177 | TLX | Telix Pharmaceuticals Limited | 4.30B | 8.91% | 1,078,591 | 890.79M |
| 178 | ITGR | Integer Holdings Corporation | 4.29B | 0.06% | 515,953 | 1.84B |
| 179 | ADPT | Adaptive Biotechnologies Corporation | 4.26B | 7.67% | 4,124,241 | 308.08M |
| 180 | IOVA | Iovance Biotherapeutics, Inc. | 4.24B | 1.08% | 11,091,432 | 324.97M |
| 181 | HTFL | HeartFlow, Inc. | 4.20B | -2.44% | 2,031,876 | 212.07M |
| 182 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.16B | -1.46% | 1,828,391 | -665.00K |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.16B | -0.47% | 2,742,783 | 10.35M |
| 184 | CELC | Celcuity Inc. | 4.05B | -0.99% | 783,502 | - |
| 185 | INDV | Indivior Pharmaceuticals, Inc. | 4.04B | -0.73% | 2,700,649 | 1.33B |
| 186 | TNGX | Tango Therapeutics, Inc. | 4.03B | -2.65% | 1,744,572 | 53.81M |
| 187 | NVST | Envista Holdings Corporation | 3.97B | -4.11% | 4,750,431 | 2.86B |
| 188 | PLSE | Pulse Biosciences, Inc. | 3.94B | 1.83% | 472,208 | 1.19M |
| 189 | ELVN | Enliven Therapeutics, Inc. | 3.91B | -1.97% | 866,955 | - |
| 190 | ICUI | ICU Medical, Inc. | 3.90B | -1.12% | 196,453 | 2.16B |
| 191 | ABCL | AbCellera Biologics Inc. | 3.70B | 2.15% | 3,728,559 | 66.17M |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.69B | -2.45% | 452,261 | 825.34M |
| 193 | IDYA | IDEAYA Biosciences, Inc. | 3.63B | -0.97% | 617,082 | 234.13M |
| 194 | OGN | Organon & Co. | 3.59B | 0.07% | 3,594,072 | 6.13B |
| 195 | NHC | National HealthCare Corporation | 3.55B | -0.50% | 58,202 | 1.56B |
| 196 | OPCH | Option Care Health, Inc. | 3.52B | -1.96% | 2,534,033 | 5.69B |
| 197 | VKTX | Viking Therapeutics, Inc. | 3.49B | -5.01% | 2,807,989 | - |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.43B | -2.15% | 623,982 | 606.33M |
| 199 | LEGN | Legend Biotech Corporation | 3.42B | -4.64% | 3,477,075 | 1.27B |
| 200 | GRAL | GRAIL, Inc. | 3.39B | 0.48% | 1,514,688 | 165.26M |
| 201 | DYN | Dyne Therapeutics, Inc. | 3.34B | -3.35% | 3,029,307 | - |
| 202 | DNLI | Denali Therapeutics Inc. | 3.26B | -3.96% | 1,813,874 | 3.60M |
| 203 | VCYT | Veracyte, Inc. | 3.23B | -2.60% | 1,760,694 | 561.90M |
| 204 | AVAH | Aveanna Healthcare Holdings Inc. | 3.12B | -0.49% | 3,479,668 | 2.60B |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.10B | 1.04% | 1,927,929 | 117.00M |
| 206 | TMDX | TransMedics Group, Inc. | 3.05B | 2.60% | 942,785 | 668.47M |
| 207 | GRDN | Guardian Pharmacy Services, Inc. | 3.04B | 3.25% | 719,479 | 1.46B |
| 208 | CLDX | Celldex Therapeutics, Inc. | 3.02B | -1.71% | 686,380 | 158.00K |
| 209 | WRBY | Warby Parker Inc. | 3.01B | -5.33% | 2,875,112 | 911.61M |
| 210 | QURE | uniQure N.V. | 2.99B | -4.07% | 1,214,969 | 18.67M |
| 211 | ARQT | Arcutis Biotherapeutics, Inc. | 2.96B | -3.13% | 3,459,262 | 463.98M |
| 212 | MBX | MBX Biosciences, Inc. | 2.94B | 2.67% | 652,589 | - |
| 213 | ATRC | AtriCure, Inc. | 2.86B | 0.77% | 1,432,304 | 569.62M |
| 214 | BKD | Brookdale Senior Living Inc. | 2.83B | -0.50% | 2,888,141 | 2.93B |
| 215 | WGS | GeneDx Holdings Corp. | 2.82B | 5.46% | 833,788 | 454.43M |
| 216 | ZLAB | Zai Lab Limited | 2.78B | 0.90% | 937,284 | 449.61M |
| 217 | GPCR | Structure Therapeutics Inc. | 2.78B | 1.33% | 1,470,351 | - |
| 218 | RGC | Regencell Bioscience Holdings Limited | 2.77B | -2.44% | 71,952 | - |
| 219 | CDNA | CareDx, Inc. | 2.72B | 0.52% | 950,020 | 458.09M |
| 220 | IMNM | Immunome, Inc. | 2.72B | -2.44% | 1,332,793 | 4.02M |
| 221 | PHVS | Pharvaris N.V. | 2.67B | -2.06% | 1,751,076 | - |
| 222 | NEOG | Neogen Corporation | 2.67B | 2.51% | 3,282,401 | 870.40M |
| 223 | AXGN | Axogen, Inc. | 2.64B | 2.70% | 1,375,762 | 251.17M |
| 224 | PRVA | Privia Health Group, Inc. | 2.60B | -2.49% | 1,233,801 | 2.36B |
| 225 | IRON | Disc Medicine, Inc. | 2.58B | -2.35% | 603,837 | - |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.58B | -2.70% | 1,251,049 | 36.77M |
| 227 | MLYS | Mineralys Therapeutics, Inc. | 2.56B | -0.14% | 1,781,062 | - |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.55B | -2.21% | 1,186,385 | 3.37B |
| 229 | NAMS | NewAmsterdam Pharma Company N.V. | 2.53B | -5.37% | 1,732,831 | 7.12M |
| 230 | PGEN | Precigen, Inc. | 2.51B | 2.19% | 2,779,286 | 85.72M |
| 231 | CLOV | Clover Health Investments, Corp. | 2.48B | -8.63% | 9,656,441 | 2.48B |
| 232 | VRDN | Viridian Therapeutics, Inc. | 2.47B | -1.67% | 1,210,820 | 71.13M |
| 233 | HRMY | Harmony Biosciences Holdings, Inc. | 2.46B | 1.52% | 1,212,497 | 959.90M |
| 234 | NEO | NeoGenomics, Inc. | 2.43B | 2.61% | 2,425,328 | 766.30M |
| 235 | VERA | Vera Therapeutics, Inc. | 2.43B | -1.12% | 10,493,143 | - |
| 236 | SUPN | Supernus Pharmaceuticals, Inc. | 2.40B | -0.51% | 669,219 | 830.44M |
| 237 | HCM | HUTCHMED (China) Limited | 2.36B | 0.44% | 68,819 | 549.12M |
| 238 | BEAM | Beam Therapeutics Inc. | 2.32B | -3.73% | 2,468,841 | 156.04M |
| 239 | SLS | SELLAS Life Sciences Group, Inc. | 2.28B | -3.71% | 5,244,009 | - |
| 240 | NKTR | Nektar Therapeutics | 2.28B | -2.72% | 1,257,781 | 54.59M |
| 241 | OCUL | Ocular Therapeutix, Inc. | 2.24B | -4.94% | 2,098,595 | 52.06M |
| 242 | TRLV | Trulieve Cannabis Corp. | 2.23B | -0.17% | 1,610,269 | 1.14B |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | -1.97% | 767,129 | 1.10B |
| 244 | SRPT | Sarepta Therapeutics, Inc. | 2.19B | -0.96% | 2,534,666 | 1.97B |
| 245 | PVLA | Palvella Therapeutics, Inc. | 2.18B | -0.31% | 215,611 | - |
| 246 | INSP | Inspire Medical Systems, Inc. | 2.16B | 0.38% | 838,104 | 898.74M |
| 247 | ALHC | Alignment Healthcare, Inc. | 2.15B | -19.86% | 28,549,991 | 4.58B |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | -1.71% | 941,979 | 311.51M |
| 249 | TRVI | Trevi Therapeutics, Inc. | 2.14B | -5.35% | 2,568,290 | - |
| 250 | UFPT | UFP Technologies, Inc. | 2.13B | -0.91% | 111,179 | 631.64M |
| 251 | ESTA | Establishment Labs Holdings Inc. | 2.13B | -0.61% | 210,438 | 245.82M |
| 252 | PGNY | Progyny, Inc. | 2.13B | -0.32% | 690,696 | 1.31B |
| 253 | BHC | Bausch Health Companies Inc. | 2.12B | -4.22% | 1,611,550 | 10.85B |
| 254 | ADUS | Addus HomeCare Corporation | 2.12B | -1.24% | 281,844 | 1.48B |
| 255 | MD | Pediatrix Medical Group, Inc. | 2.12B | -0.82% | 804,388 | 1.95B |
| 256 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.09B | -0.85% | 6,112,928 | 940.61M |
| 257 | ZBIO | Zenas BioPharma, Inc. | 2.08B | 0.06% | 715,982 | 1.00M |
| 258 | GENB | Generate Biomedicines, Inc. | 2.08B | 1.19% | 959,203 | 26.48M |
| 259 | BFLY | Butterfly Network, Inc. | 2.08B | 5.26% | 7,109,590 | 112.14M |
| 260 | KOD | Kodiak Sciences Inc. | 2.07B | -0.45% | 819,594 | - |
| 261 | RAPP | Rapport Therapeutics, Inc. | 2.04B | -3.14% | 189,311 | 20.00M |
| 262 | URGN | UroGen Pharma Ltd. | 2.04B | -2.11% | 545,777 | 188.73M |
| 263 | NUVB | Nuvation Bio Inc. | 2.04B | -2.36% | 7,052,347 | 169.90M |
| 264 | VCEL | Vericel Corporation | 2.03B | 0.30% | 654,760 | 306.30M |
| 265 | ALMR | Alamar Biosciences, Inc. | 2.00B | 2.72% | 472,717 | 100.42M |
| 266 | ASTH | Astrana Health, Inc. | 1.96B | -3.16% | 314,313 | 3.84B |
| 267 | XRAY | DENTSPLY SIRONA Inc. | 1.96B | -5.30% | 4,916,967 | 3.64B |
| 268 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | -1.23% | 1,354,031 | 98.34M |
| 269 | ADMA | ADMA Biologics, Inc. | 1.93B | -5.80% | 3,589,215 | 512.28M |
| 270 | CMPS | COMPASS Pathways plc | 1.91B | -5.02% | 2,106,365 | - |
| 271 | MESO | Mesoblast Limited | 1.91B | -1.86% | 182,498 | 120.25M |
| 272 | GHRS | GH Research PLC | 1.89B | -1.22% | 140,247 | - |
| 273 | PRGO | Perrigo Company plc | 1.88B | -0.66% | 2,281,528 | 4.14B |
| 274 | COAG | Hemab Therapeutics Holdings, Inc. | 1.88B | -0.49% | 256,938 | - |
| 275 | NVCR | NovoCure Limited | 1.88B | -0.43% | 914,846 | 699.19M |
| 276 | SNDA | Sonida Senior Living, Inc. | 1.88B | -0.35% | 298,962 | 481.07M |
| 277 | FTRE | Fortrea Holdings Inc. | 1.88B | 13.33% | 1,947,081 | 2.68B |
| 278 | BHVN | Biohaven Ltd. | 1.86B | -2.37% | 3,082,896 | - |
| 279 | ZYME | Zymeworks Inc. | 1.85B | -2.98% | 552,148 | 37.13M |
| 280 | LMAT | LeMaitre Vascular, Inc. | 1.84B | -0.66% | 303,213 | 262.43M |
| 281 | STOK | Stoke Therapeutics, Inc. | 1.82B | -4.90% | 1,071,816 | 27.59M |
| 282 | SEPN | Septerna, Inc. | 1.81B | -1.74% | 269,392 | 98.88M |
| 283 | ALVO | Alvotech | 1.79B | -0.59% | 610,021 | 494.61M |
| 284 | LKFT | Lakefront Biotherapeutics NV | 1.79B | 4.46% | 890,382 | 1.13B |
| 285 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.79B | 2.84% | 2,676,766 | 208.78M |
| 286 | BLFS | BioLife Solutions, Inc. | 1.78B | 2.71% | 914,518 | 106.69M |
| 287 | SGRY | Surgery Partners, Inc. | 1.77B | -2.78% | 1,911,231 | 3.37B |
| 288 | NBTX | Nanobiotix S.A. | 1.77B | -0.98% | 135,729 | 38.27M |
| 289 | VIR | Vir Biotechnology, Inc. | 1.77B | -3.02% | 2,284,809 | 303.23M |
| 290 | XNCR | Xencor, Inc. | 1.77B | -3.18% | 1,732,995 | 104.97M |
| 291 | TYRA | Tyra Biosciences, Inc. | 1.75B | 1.44% | 1,142,326 | - |
| 292 | KLRA | Kailera Therapeutics, Inc. | 1.74B | -2.18% | 726,406 | - |
| 293 | SDGR | Schrödinger, Inc. | 1.74B | 12.05% | 3,797,027 | 259.04M |
| 294 | RXRX | Recursion Pharmaceuticals, Inc. | 1.74B | -4.99% | 11,881,322 | 54.86M |
| 295 | KARD | Kardigan, Inc. | 1.74B | -2.52% | 344,901 | - |
| 296 | PSNL | Personalis, Inc. | 1.72B | -1.17% | 2,426,603 | 69.67M |
| 297 | BRVE | Braveheart Bio, Inc. | 1.71B | -1.15% | 274,956 | - |
| 298 | TSHA | Taysha Gene Therapies, Inc. | 1.65B | 1.00% | 5,148,771 | 5.49M |
| 299 | ATEC | Alphatec Holdings, Inc. | 1.65B | -1.84% | 2,867,187 | 815.05M |
| 300 | IMCR | Immunocore Holdings plc | 1.64B | -2.11% | 653,904 | 430.78M |
| 301 | ANAB | AnaptysBio, Inc. | 1.62B | 1.05% | 351,768 | 232.39M |
| 302 | SNDX | Syndax Pharmaceuticals, Inc. | 1.62B | -1.42% | 1,128,103 | 252.25M |
| 303 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -4.30% | 3,990,812 | 59.51M |
| 304 | FRNM | Freenome, Inc. | 1.57B | -2.14% | 523,403 | 35.41M |
| 305 | ETON | Eton Pharmaceuticals, Inc. | 1.57B | -4.67% | 543,868 | 105.60M |
| 306 | INBX | Inhibrx Biosciences, Inc. | 1.55B | -4.40% | 251,600 | 1.30M |
| 307 | AGL | agilon health, inc. | 1.55B | -0.28% | 202,624 | 5.92B |
| 308 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | 2.43% | 464,350 | 978.38M |
| 309 | DMRA | Damora Therapeutics, Inc. | 1.53B | -12.82% | 1,677,941 | - |
| 310 | LTGO | Latigo Biotherapeutics, Inc. | 1.53B | 1.63% | 221,444 | - |
| 311 | NVAX | Novavax, Inc. | 1.52B | -3.75% | 3,331,570 | 413.80M |
| 312 | AVLN | Avalyn Pharma Inc. | 1.52B | -2.00% | 227,079 | - |
| 313 | ARDT | Ardent Health, Inc. | 1.51B | -2.82% | 528,219 | 6.41B |
| 314 | INVA | Innoviva, Inc. | 1.51B | -0.29% | 1,102,032 | 440.00M |
| 315 | HCSG | Healthcare Services Group, Inc. | 1.50B | -0.59% | 481,461 | 1.86B |
| 316 | BCAX | Bicara Therapeutics Inc. | 1.50B | -2.28% | 706,493 | - |
| 317 | KMTS | Kestra Medical Technologies, Ltd. | 1.50B | 4.66% | 888,288 | 106.73M |
| 318 | INNV | InnovAge Holding Corp. | 1.49B | 1.39% | 247,628 | 989.71M |
| 319 | OMCL | Omnicell, Inc. | 1.49B | -2.63% | 642,560 | 1.25B |
| 320 | NUTX | Nutex Health Inc. | 1.47B | -0.78% | 126,408 | 846.72M |
| 321 | KRSA | Korsana Biosciences, Inc. | 1.46B | 1.49% | 118,936 | - |
| 322 | AAPG | Ascentage Pharma Group International | 1.46B | -2.50% | 4,287 | 94.61M |
| 323 | AZTA | Azenta, Inc. | 1.45B | 3.09% | 718,485 | 613.81M |
| 324 | PAHC | Phibro Animal Health Corporation | 1.42B | -2.53% | 322,819 | 1.52B |
| 325 | CNMD | CONMED Corporation | 1.41B | 1.23% | 458,087 | 1.37B |
| 326 | PNTG | The Pennant Group, Inc. | 1.40B | -0.35% | 240,496 | 1.10B |
| 327 | LBRX | LB Pharmaceuticals Inc | 1.39B | -4.01% | 320,546 | - |
| 328 | AVBP | ArriVent BioPharma, Inc. | 1.38B | -2.10% | 337,266 | - |
| 329 | TRAX | First Tracks Biotherapeutics, Inc. | 1.37B | 2.40% | 526,049 | - |
| 330 | DRTS | Alpha Tau Medical Ltd. | 1.37B | 3.26% | 412,397 | - |
| 331 | XERS | Xeris Biopharma Holdings, Inc. | 1.37B | -1.06% | 1,180,910 | 335.41M |
| 332 | ABSI | Absci Corporation | 1.36B | -1.85% | 2,331,809 | 1.56M |
| 333 | MAZE | Maze Therapeutics, Inc. | 1.35B | -1.78% | 437,398 | 20.00M |
| 334 | SVRA | Savara Inc. | 1.34B | -1.50% | 1,301,414 | - |
| 335 | AMN | AMN Healthcare Services, Inc. | 1.32B | -0.12% | 1,107,238 | 3.43B |
| 336 | CGEM | Cullinan Therapeutics, Inc. | 1.32B | 0.69% | 1,060,744 | - |
| 337 | VOR | Vor Biopharma Inc. | 1.32B | -3.29% | 729,843 | - |
| 338 | RARE | Ultragenyx Pharmaceutical Inc. | 1.28B | -3.97% | 5,655,000 | 717.00M |
| 339 | CERT | Certara, Inc. | 1.28B | 5.00% | 2,121,487 | 421.75M |
| 340 | ORIC | ORIC Pharmaceuticals, Inc. | 1.28B | -2.29% | 2,052,551 | - |
| 341 | HROW | Harrow, Inc. | 1.27B | -0.68% | 542,878 | 275.59M |
| 342 | AKTS | Aktis Oncology, Inc. | 1.25B | -3.28% | 290,429 | 10.06M |
| 343 | OMER | Omeros Corporation | 1.24B | -1.66% | 1,655,522 | 38.42M |
| 344 | AORT | Artivion, Inc. | 1.24B | 1.64% | 949,006 | 471.47M |
| 345 | SPTX | Seaport Therapeutics, Inc. | 1.23B | -7.04% | 158,967 | - |
| 346 | REPL | Replimune Group, Inc. | 1.23B | -0.61% | 2,233,135 | - |
| 347 | MGTX | MeiraGTx Holdings plc | 1.23B | -0.93% | 1,025,613 | 397.50M |
| 348 | IART | Integra LifeSciences Holdings Corporation | 1.22B | -0.13% | 1,077,644 | 1.65B |
| 349 | USPH | U.S. Physical Therapy, Inc. | 1.22B | 1.53% | 308,384 | 804.27M |
| 350 | OMDA | Omada Health, Inc. | 1.20B | -4.05% | 1,662,767 | 309.76M |
| 351 | TDOC | Teladoc Health, Inc. | 1.20B | 1.23% | 3,551,754 | 2.49B |
| 352 | GDRX | GoodRx Holdings, Inc. | 1.19B | -1.97% | 777,025 | 785.23M |
| 353 | ANRO | Alto Neuroscience, Inc. | 1.19B | -4.51% | 420,380 | - |
| 354 | CRON | Cronos Group Inc. | 1.18B | -1.08% | 591,392 | 179.09M |
| 355 | IMTX | Immatics N.V. | 1.18B | -0.23% | 327,112 | 47.65M |
| 356 | OPK | OPKO Health, Inc. | 1.17B | 0.64% | 1,424,440 | 587.90M |
| 357 | MNKD | MannKind Corporation | 1.14B | -5.07% | 3,698,100 | 393.63M |
| 358 | TNDM | Tandem Diabetes Care, Inc. | 1.13B | -3.15% | 2,379,782 | 1.04B |
| 359 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 3.51% | 280,169 | 1.04B |
| 360 | STAA | STAAR Surgical Company | 1.13B | -2.71% | 1,079,935 | 339.59M |
| 361 | GLUE | Monte Rosa Therapeutics, Inc. | 1.11B | -6.55% | 1,126,073 | 28.73M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.11B | -8.18% | 1,997,751 | 337.34M |
| 363 | JBIO | Jade Biosciences, Inc. | 1.11B | -4.40% | 849,771 | - |
| 364 | BVS | Bioventus Inc. | 1.09B | -1.22% | 463,363 | 581.85M |
| 365 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | -1.22% | 1,397,081 | - |
| 366 | SLBT | SL Science Holding Limited | 1.09B | -7.73% | 60,846 | 3.27M |
| 367 | ALMS | Alumis Inc. | 1.09B | -8.89% | 4,004,535 | 7.40M |
| 368 | CSTL | Castle Biosciences, Inc. | 1.08B | 6.16% | 519,837 | 357.28M |
| 369 | ATTO | Attovia Therapeutics, Inc. | 1.08B | -3.34% | 198,400 | 1.80M |
| 370 | APMD | Apnimed, Inc. | 1.06B | 0.04% | 350,383 | 115.12M |
| 371 | IRMD | IRADIMED CORPORATION | 1.05B | -0.15% | 95,962 | 86.34M |
| 372 | ODTX | Odyssey Therapeutics, Inc. | 1.05B | -9.36% | 274,331 | 99.00K |
| 373 | OBX | Obsidian Therapeutics, Inc. | 1.05B | -6.08% | 472,266 | - |
| 374 | MLTX | MoonLake Immunotherapeutics | 1.04B | -3.79% | 1,797,994 | - |
| 375 | ENOV | Enovis Corporation | 1.03B | -1.54% | 2,658,432 | 2.30B |
| 376 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.01B | -1.13% | 354,411 | 730.02M |
| 377 | KURA | Kura Oncology, Inc. | 1.01B | -2.25% | 1,827,283 | 77.23M |
| 378 | JANX | Janux Therapeutics, Inc. | 1.01B | -5.03% | 1,008,478 | 24.00M |
| 379 | ABUS | Arbutus Biopharma Corporation | 1.00B | -1.36% | 4,252,429 | 181.72M |
| 380 | GMRS | GMR Solutions Inc. | 989.40M | -4.00% | 1,537,128 | 5.88B |
| 381 | SGP | SpyGlass Pharma, Inc. | 968.65M | 1.05% | 131,672 | - |
| 382 | ANL | Adlai Nortye Group Ltd. | 963.39M | -6.09% | 171,304 | 18.06M |
| 383 | CBLL | CeriBell, Inc. | 960.99M | 2.92% | 323,521 | 101.96M |
| 384 | PCRX | Pacira BioSciences, Inc. | 959.87M | -2.43% | 824,513 | 746.16M |
| 385 | HELP | Cybin Inc. | 958.55M | -3.60% | 1,195,675 | - |
| 386 | SANA | Sana Biotechnology, Inc. | 945.98M | -1.25% | 2,472,695 | - |
| 387 | IVA | Inventiva S.A. | 936.99M | -0.52% | 2,633,766 | 7.94M |
| 388 | FTH | Faeth Therapeutics, Inc. | 913.98M | -9.52% | 209,046 | - |
| 389 | SLDB | Solid Biosciences Inc. | 897.48M | -4.23% | 1,514,321 | - |
| 390 | LXRX | Lexicon Pharmaceuticals, Inc. | 894.36M | 1.52% | 2,508,530 | 41.47M |
| 391 | TBPH | Theravance Biopharma, Inc. | 884.70M | 0.06% | 403,744 | 104.31M |
| 392 | WVE | Wave Life Sciences, Inc. | 878.83M | -2.62% | 2,286,378 | 65.37M |
| 393 | IMMX | Immix Biopharma, Inc. | 868.49M | -0.57% | 1,054,947 | - |
| 394 | HSTM | HealthStream, Inc. | 866.96M | 0.07% | 185,219 | 321.12M |
| 395 | BBNX | Beta Bionics, Inc. | 865.15M | 14.94% | 1,702,629 | 119.01M |
| 396 | AVTX | Avalo Therapeutics, Inc. | 861.83M | -0.68% | 1,102,736 | 59.00K |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 855.73M | -4.96% | 1,733,327 | - |
| 398 | INMD | InMode Ltd. | 854.74M | -0.13% | 585,986 | 374.63M |
| 399 | CADL | Candel Therapeutics, Inc. | 850.89M | 4.17% | 1,065,371 | - |
| 400 | ARDX | Ardelyx, Inc. | 847.24M | -3.41% | 5,095,868 | 450.89M |
| 401 | GERN | Geron Corporation | 841.64M | -4.38% | 16,486,722 | 204.56M |
| 402 | SIBN | SI-BONE, Inc. | 831.38M | -0.80% | 429,393 | 213.60M |
| 403 | RIGL | Rigel Pharmaceuticals, Inc. | 828.64M | -2.18% | 269,844 | 276.79M |
| 404 | ACRS | Aclaris Therapeutics, Inc. | 813.27M | -2.04% | 1,331,161 | 8.22M |
| 405 | AVR | Anteris Technologies Global Corp. | 812.80M | -4.36% | 583,666 | 2.24M |
| 406 | CBIO | Crescent Biopharma, Inc. | 804.66M | -4.47% | 357,961 | 11.88M |
| 407 | CLYM | Climb Bio, Inc. | 798.94M | -4.46% | 1,552,836 | - |
| 408 | VREX | Varex Imaging Corporation | 778.47M | 0.05% | 548,723 | 865.00M |
| 409 | AHCO | AdaptHealth Corp. | 776.44M | -1.02% | 3,395,549 | 3.36B |
| 410 | DSGN | Design Therapeutics, Inc. | 765.06M | -9.58% | 1,280,322 | - |
| 411 | GLAS | Glass House Brands Inc. | 757.71M | -0.74% | 768,198 | 176.98M |
| 412 | ACHV | Achieve Life Sciences, Inc. | 753.25M | 1.24% | 1,385,040 | - |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 752.98M | -0.94% | 552,035 | 92.01M |
| 414 | SLN | Silence Therapeutics plc | 750.21M | -4.59% | 1,235,925 | 615.00K |
| 415 | PHAR | Pharming Group N.V. | 743.57M | -2.50% | 15,274 | 366.48M |
| 416 | ANNX | Annexon, Inc. | 743.15M | -0.76% | 2,960,538 | - |
| 417 | QDEL | QuidelOrtho Corporation | 728.96M | -4.41% | 3,116,938 | 2.67B |
| 418 | AURA | Aura Biosciences, Inc. | 717.64M | -1.28% | 712,284 | - |
| 419 | NVCT | Nuvectis Pharma, Inc. | 714.19M | -6.12% | 166,135 | - |
| 420 | COLL | Collegium Pharmaceutical, Inc. | 711.01M | -4.25% | 954,001 | 808.21M |
| 421 | GYRE | Gyre Therapeutics, Inc. | 709.37M | - | 97,726 | 109.82M |
| 422 | DBVT | DBV Technologies S.A. | 707.16M | -4.78% | 175,072 | 5.04M |
| 423 | MNPR | Monopar Therapeutics Inc. | 700.28M | -3.68% | 96,983 | - |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 691.82M | -3.32% | 916,533 | 136.07M |
| 425 | MDXG | MiMedx Group, Inc. | 687.99M | 1.72% | 1,147,376 | 355.17M |
| 426 | BLSM | BlossomHill Therapeutics, Inc. | 679.37M | 1.98% | 148,830 | - |
| 427 | SOPH | SOPHiA GENETICS SA | 677.62M | 1.27% | 1,843,843 | 86.17M |
| 428 | NGNE | Neurogene Inc. | 674.18M | -4.32% | 147,589 | 925.00K |
| 429 | MPLT | MapLight Therapeutics, Inc. | 671.35M | -8.14% | 402,324 | - |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 670.87M | -2.64% | 1,124,736 | 389.32M |
| 431 | VSTM | Verastem, Inc. | 664.74M | -2.26% | 2,840,151 | 87.53M |
| 432 | SSII | SS Innovations International, Inc. | 661.27M | -2.51% | 57,071 | 52.40M |
| 433 | AHG | Akso Health Group | 651.10M | -5.21% | 5,401 | 13.83M |
| 434 | SGMT | Sagimet Biosciences Inc. | 650.18M | -3.86% | 852,725 | - |
| 435 | STLN | Starling Oncology, Inc. | 649.21M | -2.30% | 1,173,868 | 587.24M |
| 436 | PHAT | Phathom Pharmaceuticals, Inc. | 648.15M | -5.99% | 1,641,913 | 239.66M |
| 437 | ANGO | AngioDynamics, Inc. | 648.09M | 1.10% | 661,543 | 320.17M |
| 438 | PHR | Phreesia, Inc. | 642.43M | -0.67% | 691,473 | 507.79M |
| 439 | CTKB | Cytek Biosciences, Inc. | 635.62M | 1.24% | 1,119,842 | 206.71M |
| 440 | OABI | OmniAb, Inc. | 632.45M | -2.90% | 788,806 | 38.46M |
| 441 | DRUG | Bright Minds Biosciences Inc. | 631.27M | -4.99% | 58,915 | - |
| 442 | ALT | Altimmune, Inc. | 628.29M | -2.12% | 2,339,039 | 31.00K |
| 443 | OCS | Oculis Holding AG | 621.64M | -5.00% | 159,306 | 1.45M |
| 444 | VALN | Valneva SE | 617.63M | -1.95% | 23,769 | 163.30M |
| 445 | KIDS | OrthoPediatrics Corp. | 606.79M | 4.03% | 191,948 | 252.72M |
| 446 | CRMD | CorMedix Inc. | 604.85M | -1.65% | 718,700 | 462.25M |
| 447 | AQST | Aquestive Therapeutics, Inc. | 603.71M | -1.43% | 1,607,243 | 54.09M |
| 448 | CTEV | Claritev Corporation | 602.31M | -2.47% | 116,360 | 994.67M |
| 449 | AGMB | AgomAb Therapeutics NV | 601.81M | -0.49% | 146,342 | - |
| 450 | SCTX | Scribe Therapeutics Inc. | 599.38M | 7.61% | 162,610 | 33.30M |
| 451 | STTK | Shattuck Labs, Inc. | 599.17M | -3.71% | 895,232 | 1.00M |
| 452 | ALLO | Allogene Therapeutics, Inc. | 594.24M | -3.37% | 3,138,542 | 4.64M |
| 453 | WEAV | Weave Communications, Inc. | 586.39M | 0.14% | 1,371,535 | 257.79M |
| 454 | CTMX | CytomX Therapeutics, Inc. | 586.15M | -15.94% | 7,509,835 | 18.30M |
| 455 | FLGT | Fulgent Genetics, Inc. | 585.53M | 3.05% | 479,877 | 323.93M |
| 456 | EVO | Evotec SE | 575.81M | -2.98% | 102,164 | 819.47M |
| 457 | DCTH | Delcath Systems, Inc. | 561.08M | -1.64% | 323,159 | 95.42M |
| 458 | PRME | Prime Medicine, Inc. | 558.62M | -1.26% | 2,574,422 | 4.07M |
| 459 | TECX | Tectonic Therapeutic, Inc. | 557.35M | -4.04% | 220,898 | - |
| 460 | TLRY | Tilray Brands, Inc. | 546.60M | -3.62% | 3,241,439 | 915.45M |
| 461 | ARVN | Arvinas, Inc. | 540.09M | -1.67% | 2,523,096 | 316.70M |
| 462 | ASMB | Assembly Biosciences, Inc. | 531.62M | -9.84% | 588,837 | 74.85M |
| 463 | BWAY | BrainsWay Ltd. | 531.26M | -1.25% | 123,244 | 60.70M |
| 464 | EPRX | Eupraxia Pharmaceuticals Inc. | 530.90M | 0.50% | 197,825 | - |
| 465 | OVID | Ovid Therapeutics Inc. | 529.26M | -1.09% | 988,533 | 1.58M |
| 466 | PROK | ProKidney Corp. | 526.04M | -3.87% | 1,201,056 | 818.00K |
| 467 | RGNX | REGENXBIO Inc. | 524.47M | -8.57% | 1,427,110 | 174.48M |
| 468 | EOLS | Evolus, Inc. | 522.46M | -0.25% | 637,830 | 316.49M |
| 469 | CTNM | Contineum Therapeutics, Inc. | 519.92M | -6.75% | 704,608 | - |
| 470 | EIKN | Eikon Therapeutics, Inc. | 514.03M | 1.39% | 843,447 | - |
| 471 | TCMD | Tactile Systems Technology, Inc. | 509.90M | -0.27% | 202,538 | 350.31M |
| 472 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 473 | CERS | Cerus Corporation | 503.81M | -1.96% | 1,018,971 | 221.55M |
| 474 | AUTL | Autolus Therapeutics plc | 503.05M | -2.58% | 978,726 | 117.39M |
| 475 | CAPR | Capricor Therapeutics, Inc. | 497.67M | -2.84% | 2,174,659 | 11.13M |
| 476 | ENTX | Entera Bio Ltd. | 495.19M | 1.42% | 391,293 | 42.00K |
| 477 | NPCE | NeuroPace, Inc. | 489.12M | -2.33% | 96,842 | 106.99M |
| 478 | NRC | NRC Health | 485.75M | -1.57% | 105,030 | 140.00M |
| 479 | INDP | Indaptus Therapeutics, Inc. | 485.00M | 15.92% | 1,960,465 | - |
| 480 | IRD | Opus Genetics, Inc. | 484.20M | -2.51% | 1,993,223 | 9.86M |
| 481 | PBYI | Puma Biotechnology, Inc. | 477.49M | 1.20% | 309,915 | 231.24M |
| 482 | RLMD | Relmada Therapeutics, Inc. | 473.61M | - | 1,998,601 | - |
| 483 | ZURA | Zura Bio Limited | 472.44M | -5.37% | 2,637,350 | - |
| 484 | DNA | Ginkgo Bioworks Holdings, Inc. | 470.71M | -0.29% | 734,926 | 132.42M |
| 485 | SENS | Senseonics Holdings, Inc. | 469.52M | 0.45% | 436,091 | 48.55M |
| 486 | SRTA | Strata Critical Medical, Inc. | 467.99M | -1.31% | 546,310 | 255.98M |
| 487 | PRLD | Prelude Therapeutics Incorporated | 465.54M | -1.53% | 262,713 | 22.42M |
| 488 | KMDA | Kamada Ltd. | 463.01M | -2.65% | 119,782 | 191.85M |
| 489 | ARCT | Arcturus Therapeutics Holdings Inc. | 450.22M | 3.60% | 556,075 | 29.37M |
| 490 | VOGX | Vogenx, Inc. | 448.29M | -0.65% | 149,862 | - |
| 491 | SGHT | Sight Sciences, Inc. | 446.76M | -0.25% | 88,755 | 83.38M |
| 492 | CABA | Cabaletta Bio, Inc. | 439.97M | -10.82% | 6,802,430 | - |
| 493 | ARTV | Artiva Biotherapeutics, Inc. | 435.61M | -12.13% | 584,555 | 251.00K |
| 494 | RZLT | Rezolute, Inc. | 433.54M | -2.35% | 752,958 | - |
| 495 | KYTX | Kyverna Therapeutics, Inc. | 430.43M | -5.95% | 1,070,875 | - |
| 496 | PRTA | Prothena Corporation plc | 427.64M | -5.98% | 323,436 | 54.53M |
| 497 | EVH | Evolent Health, Inc. | 422.84M | -8.78% | 5,306,306 | 2.10B |
| 498 | SPRY | ARS Pharmaceuticals, Inc. | 422.65M | -5.56% | 2,776,215 | 116.93M |
| 499 | CCCC | C4 Therapeutics, Inc. | 421.98M | - | 1,344,577 | 35.04M |
| 500 | IKT | Inhibikase Therapeutics, Inc. | 420.59M | -3.35% | 480,800 | 1.00 |